Food and Drug Administration (FDA) Postmarket Reported Side Effects and Adverse Events Associated With Pulmonary Hypertension Therapy in Pediatric Patients
Pediatric Cardiology - United States
doi 10.1007/s00246-013-0688-2
Full Text
Open PDFAbstract
Available in full text
Date
March 27, 2013
Authors
Publisher
Springer Science and Business Media LLC